Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Okan Elidemir

Pediatric Pulmonology Pensacola, FL Medical Doctor

NPI 1073693313 CMS profile 230550

5153 North 9Th Ave., Nemours Children's Clinic, Pensacola, FL 32504

Open in the dashboard

General payments

$3,121

167 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$610,809 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Okan Elidemir of Pensacola, FL is reported in the CMS Open Payments database as having received $3,121 across 167 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $610,809 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 81st percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $512 18
2024 General $422 23
2023 General $388 21
2022 General $365 24
2021 General $675 37
2020 General $362 19
2019 General $398 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Okan Elidemir
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Okan Elidemir were reported at $512. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Okan Elidemir Pediatric Pulmonology median Middle half National median
2019 $398 $151 $59–$495 $163
2020 $362 $107 $34–$339 $114
2021 $675 $125 $40–$511 $132
2022 $365 $133 $49–$428 $149
2023 $388 $138 $44–$494 $160
2024 $422 $132 $46–$398 $164
2025 $512 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $414 24 payments
  2. GlaxoSmithKline, LLC. $374 19 payments
  3. Electromed, Inc. $358 34 payments
  4. Regeneron Healthcare Solutions, Inc. $268 11 payments
  5. Baxter Healthcare $265 5 payments
  6. AbbVie, Inc. $264 15 payments
  7. Chiesi USA, Inc. $202 9 payments
  8. Genentech USA, Inc. $179 9 payments
  9. Nestle HealthCare Nutrition Inc. $148 7 payments
  10. Advanced Respiratory, Inc $119 6 payments
  11. Other $532 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,121 167 payments
Products named General payments · program years 2019–2025
  1. NUCALA $257 13 payments
  2. TEZSPIRE $243 13 payments
  3. CREON $222 13 payments
  4. PERTZYE $202 9 payments
  5. SMARTVEST Hfcwo $190 14 payments
  6. DUPIXENT $187 8 payments
  7. SMARTVEST Hfcwo $168 20 payments
  8. COSEAL $143 1 payment
  9. ZENPEP $128 6 payments
  10. BETHKIS $128 6 payments
  11. Other $1,316 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

167 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record